Personalized diagnosis by cached solutions with hypertension as a study model.

Statistical modeling of links between genetic profiles with environmental and clinical data to aid in medical diagnosis is a challenge. Here, we present a computational approach for rapidly selecting important clinical data to assist in medical decisions based on personalized genetic profiles. What could take hours or days of computing is available on-the-fly, making this strategy feasible to implement as a routine without demanding great computing power. The key to rapidly obtaining an optimal/nearly optimal mathematical function that can evaluate the "disease stage" by combining information of genetic profiles with personal clinical data is done by querying a precomputed solution database. The database is previously generated by a new hybrid feature selection method that makes use of support vector machines, recursive feature elimination and random sub-space search. Here, to evaluate the method, data from polymorphisms in the renin-angiotensin-aldosterone system genes together with clinical data were obtained from patients with hypertension and control subjects. The disease "risk" was determined by classifying the patients' data with a support vector machine model based on the optimized feature; then measuring the Euclidean distance to the hyperplane decision function. Our results showed the association of renin-angiotensin-aldosterone system gene haplotypes with hypertension. The association of polymorphism patterns with different ethnic groups was also tracked by the feature selection process. A demonstration of this method is also available online on the project's web site.

[1]  Jan M. Van Campenhout,et al.  On the Possible Orderings in the Measurement Selection Problem , 1977, IEEE Transactions on Systems, Man, and Cybernetics.

[2]  Bernhard E. Boser,et al.  A training algorithm for optimal margin classifiers , 1992, COLT '92.

[3]  Thorsten Joachims,et al.  Learning to classify text using support vector machines - methods, theory and algorithms , 2002, The Kluwer international series in engineering and computer science.

[4]  John Quackenbush,et al.  A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. , 1997, The Journal of clinical investigation.

[5]  A. de la Sierra,et al.  Molecular Basis of Salt Sensitivity in Human Hypertension: Evaluation of Renin-Angiotensin-Aldosterone System Gene Polymorphisms , 2001, Hypertension.

[6]  Thorsten Joachims,et al.  Making large-scale support vector machine learning practical , 1999 .

[7]  A. Dominiczak,et al.  Genetics of Hypertension: Lessons Learnt from Mendelian and Polygenic Syndromes , 2004, Clinical and experimental hypertension.

[8]  R Kreutz,et al.  A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. , 1995, The New England journal of medicine.

[9]  Jason Weston,et al.  Gene Selection for Cancer Classification using Support Vector Machines , 2002, Machine Learning.

[10]  J. Connor,et al.  Assignment of the human angiotensin gene to chromosome 1q42–q43 by nonisotopic in situ hybridization , 1990 .

[11]  W. Grzeszczak,et al.  Angiotensin II type 1 receptor gene A1166C polymorphism is associated with the increased risk of pregnancy-induced hypertension. , 2000, Medical science monitor : international medical journal of experimental and clinical research.

[12]  V. Álvarez,et al.  Association between the NOS3 (-786 T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease. , 2001, Nitric oxide : biology and chemistry.

[13]  B. Baudin Angiotensin I-Converting Enzyme Gene Polymorphism and Drug Response , 2000, Clinical chemistry and laboratory medicine.

[14]  L. Tiret,et al.  Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. , 1994, Hypertension.

[15]  B. Baudin Angiotensin II receptor polymorphisms in hypertension. Pharmacogenomic considerations. , 2002, Pharmacogenomics.

[16]  D. Cusi,et al.  Association between aldosterone synthase (CYP11B2) polymorphism and left ventricular mass in human essential hypertension. , 2004, Journal of the American College of Cardiology.

[17]  Thorsten Joachims,et al.  Estimating the Generalization Performance of an SVM Efficiently , 2000, ICML.

[18]  R. Ravazzolo,et al.  Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension. , 2000, Kidney international.

[19]  S. Umemura,et al.  Essential hypertension and 5' upstream core promoter region of human angiotensinogen gene. , 1997, Hypertension.

[20]  F. Cambien,et al.  Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals. , 1996, Hypertension.

[21]  Andrew Kusiak,et al.  Data mining and genetic algorithm based gene/SNP selection , 2004, Artif. Intell. Medicine.

[22]  Vladimir N. Vapnik,et al.  The Nature of Statistical Learning Theory , 2000, Statistics for Engineering and Information Science.

[23]  J. Lalouel,et al.  Haplotypes of angiotensinogen in essential hypertension. , 1997, American journal of human genetics.

[24]  Steven C. Hunt,et al.  Molecular basis of human hypertension: Role of angiotensinogen , 1992, Cell.